Radiographic progression · patients with axSpA (AS and nr‐axSpA)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of serious adverse events · patients with axSpA (AS and nr‐axSpA)
Traditional NSAIDs showed no clear difference in number of serious adverse events compared with placebo (moderate certainty).
1 finding from 1 review
RR 1.69 [0.36, 7.97]
671 participants
Moderate
Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · patients with axSpA (AS and nr‐axSpA)
1 finding from 1 review
no estimate extracted
349 participants
High
Withdrawals due to adverse events · patients with axSpA (AS and nr‐axSpA)
COX‐2 NSAIDs showed no clear difference in withdrawals due to adverse events compared with placebo (low certainty).
1 finding from 1 review
RR 2.14 [0.36, 12.56]
669 participants
Low
Intervention not reported
Number of patients with at least 30% pain reduction · Patients with fibromyalgia
It is very uncertain whether the intervention changes number of patients with at least 30% pain reduction (very low certainty).
1 finding from 1 review
Intervention not reported
Number of patients with a clinically important global improvement · Patients with fibromyalgia
It is very uncertain whether the intervention changes number of patients with a clinically important global improvement (very low certainty).
1 finding from 1 review
Intervention not reported
Fatigue (lower scores mean less fatigue) · Patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Sleep problems (lower scores mean less sleep problems) · Patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Depression (lower scores mean less depression) · Patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Discontinuation due to adverse events · Patients with fibromyalgia
It is very uncertain whether the intervention changes discontinuation due to adverse events (very low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · Patients with fibromyalgia
It is very uncertain whether the intervention changes serious adverse events (very low certainty).
1 finding from 1 review
Intervention not reported
ACR 50 American College of Rheumatology improvement criteria · patients with rheumatoid arthritis
The intervention probably leads to higher ACR 50 American College of Rheumatology improvement criteria (moderate certainty).
1 finding from 1 review
Intervention not reported
Remission3 · patients with rheumatoid arthritis
1 finding from 1 review
Intervention not reported
Functional Status Health Assessment Questionnaire Disability Index . Scale from: 0 to 3 · patients with rheumatoid arthritis
1 finding from 1 review
Intervention not reported
Health‐Related Quality of Life at least 20% improvement · patients with rheumatoid arthritis
The intervention showed no clear difference in health‐Related Quality of Life at least 20% improvement (moderate certainty).
1 finding from 1 review
Intervention not reported
Radiographic Progression Increase in erosion scores of > 3 units · patients with rheumatoid arthritis
The intervention probably leads to lower radiographic Progression Increase in erosion scores of > 3 units (moderate certainty).
1 finding from 1 review
Intervention not reported
Discontinuations due to adverse events · patients with rheumatoid arthritis
The intervention leads to higher discontinuations due to adverse events (high certainty).
1 finding from 1 review
Intervention not reported
Serious Adverse Events · patients with rheumatoid arthritis
The intervention showed no clear difference in serious Adverse Events (moderate certainty).
1 finding from 1 review
Intervention not reported
Pain Global pain 0‐3 (higher scores mean worse) · patients with treating osteoarthritis
1 finding from 1 review
Intervention not reported
Adverse events Adverse event episodes (n) reported · patients with treating osteoarthritis
The intervention probably leads to lower adverse events Adverse event episodes (n) reported (moderate certainty).
1 finding from 1 review